Literature DB >> 16246009

Spectroscopic studies of phospholamban variants in phospholipid bilayers.

J C Clayton1, E Hughes, D A Middleton.   

Abstract

Phospholamban (PLB) is a 52 amino acid transmembrane protein found in the sarcoplasmic reticulum of cardiac myocytes, where it regulates the transport of calcium ions by SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase). This work has shown that the cytoplasmic domain of PLB associates with phospholipid vesicles, possibly with the lipid polar head groups, and, in doing so, undergoes a transition from a random coil to a more helical conformation. These findings support a recent hypothesis that the cytoplasmic domain of PLB acts as a conformational switch, alternating between an orientation that lies across the membrane surface and an upright orientation that associates with the regulatory site of SERCA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246009     DOI: 10.1042/BST20050913

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  4 in total

1.  Solid-state (2)H and (15)N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: investigation of the N27A mutation.

Authors:  Shidong Chu; Aaron T Coey; Gary A Lorigan
Journal:  Biochim Biophys Acta       Date:  2009-10-17

2.  Spectroscopic validation of the pentameric structure of phospholamban.

Authors:  Nathaniel J Traaseth; Raffaello Verardi; Kurt D Torgersen; Christine B Karim; David D Thomas; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

3.  Caprine cardiac sarcoplasmic reticulum isolation and biochemical characterisation with emphasis on Ca(2+)-adenosine triphosphatase.

Authors:  Karen M D'Souza; Tester F Ashavaid
Journal:  Indian J Clin Biochem       Date:  2007-03

4.  Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Christine B Karim; Elizabeth L Lockamy; David D Thomas; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.